Contemporary off Nationwide Resilience’s acquisition of a new, state-of-the-artwork manufacturing web site in Ontario, the fledgling CDMO is putting it to the test with a large-profile partnership.
Moderna has tapped National Resilience, started in November very last yr, to manufacture mRNA vaccine compound at Resilience’s recently acquired facility in Mississauga, Canada. Whilst sparse on information, Moderna stated the substance designed at the plant will be delivered globally.
The partnership marks Moderna’s most latest foray into Canada and will come as the biotech faces a vaccine contamination scandal in Japan. In late August, Japanese pharma Takeda, which distributes Moderna’s shot in